Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Post by pennyDoctoron Oct 17, 2019 5:00pm
167 Views
Post# 30241723

Golden Cross $$$$$$

Golden Cross $$$$$$For those paying attention to technical trading. I believe we have a golden Cross emerging and not a death cross as Dimwittless is predicting.  I have been a holder of this security for 8 years or more average cost $.11 (4bagger so far)... and I have been disappointed with board members and deals that have been slow to materialize and would suggest they get rid of their current IR group replace the President and stop issuing shares with warrants.  I have read daily posts here and understand that it has been a long game of liars poker. I do believe the technology is good and proof is now completed for 1067.   All longs agree price should be higher but would we sell if the price goes to $.90, likely no.  So as trading back and forth builds a solid base here and the golden cross matures anyone that is short or waiting for a lower price will be sad when it does move.

I look forward to a news release from Zoetis that they have picked up the SGLT for Diabetes in pets.  Woli you definitely will see $3.3 if this happens.  

Remember the longer the base the higher the space.  GLTA 
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse